Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
来自MSN17 小时
Could MRI Spot 'Pre-Cancer' Lesions of the Pancreas?
Pancreatic cancer can be a silent killer -- the organ is located deep inside the body, making cancer harder to detect before ...
Actuate sees 37% cut in risk of death in Phase II pancreatic cancer trial
The trial of the company’s metastatic pancreatic cancer treatment, elraglusib, similarly saw the one-year survival rate reach ...
Actuate Therapeutics Shares Rise 12% on Positive Phase 2 Trial to Treat Metastatic ...
Shares of Actuate Therapeutics on Tuesday climbed after the company said that it received positive data from its phase 2 trial of elraglusib in combination with gemcitabine/nab-paclitaxel to treat ...
Marker Therapeutics pops on receiving $9.5M grant to advance lead asset
Marker Therapeutics (NASDAQ:MRKR) shares popped 11% Tuesday morning after the immuno-oncology company won a $9.5M grant from ...
Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line ...
Statistical Significance Met on Primary Endpoints of 1 Year Survival Rate and Median Overall SurvivalDoubling of 1 Year ...
CBSSports.com21 天
Lakers vs. Suns odds, line, spread, time: 2024 NBA Cup picks, Nov. 26 predictions from ...
The Lakers are 2-0 in NBA Cup West: Group B, while the Suns are 1-1. The Suns are 5-11 against the spread (ATS) in the 2024-25 NBA season, while the Lakers are 7-9 versus the line. Tipoff is at 10 ...